Cargando…

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy

Human microbiota influence the response of malignancies to treatment with immune checkpoint blockade; however, their impact on other forms of immunotherapy is poorly understood. This study explored the effect of blood microbiota on clinical efficacy, represented by progression-free survival (PFS) an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Duo, Wang, Xiaoli, Zhou, Xinna, Zhao, Jing, Yang, Huabing, Wang, Shuo, Morse, Michael A., Wu, Jiangping, Yuan, Yanhua, Li, Sha, Hobeika, Amy, Lyerly, Herbert Kim, Ren, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477924/ https://www.ncbi.nlm.nih.gov/pubmed/34595059 http://dx.doi.org/10.1080/2162402X.2021.1976953

Ejemplares similares

Predictive significance of T cell subset changes during ex vivo generation of adoptive cellular therapy products for the treatment of advanced non-small cell lung cancer
por: Huang, Lefu, et al.
Publicado: (2019)

Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
por: Osada, T, et al.
Publicado: (2010)

The prognostic values of CYP2B6 genetic polymorphisms and metastatic sites for advanced breast cancer patients treated with docetaxel and thiotepa
por: Song, Qingkun, et al.
Publicado: (2015)

Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
por: Morse, Michael A, et al.
Publicado: (2015)

Self-replicating messenger RNA based cancer immunotherapy
por: Lyerly, Herbert Kim
Publicado: (2023)

Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?
por: Fan, Jiaqiao, et al.
Publicado: (2018)

Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
por: Li, Qian, et al.
Publicado: (2023)

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
por: Morse, Michael A, et al.
Publicado: (2005)

Application Of Adoptive Immunotherapy In Ovarian Cancer
por: Yang, Siyu, et al.
Publicado: (2019)

Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
por: Hamilton, Erika, et al.
Publicado: (2013)

Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers
por: Kaneko, Kensuke, et al.
Publicado: (2022)

The prognostic value of peripheral CD4(+)CD25(+) T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion
por: Song, Qing-Kun, et al.
Publicado: (2015)

Pilot Study of Sentinel-Node-Based Adoptive Immunotherapy in Advanced Colorectal Cancer
por: Karlsson, Mona, et al.
Publicado: (2010)

Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
por: Hamilton, Erika, et al.
Publicado: (2012)

Clinical trials of self-replicating RNA-based cancer vaccines
por: Morse, Michael A., et al.
Publicado: (2023)

Adoptive T Cell Immunotherapy for Cancer
por: Perica, Karlo, et al.
Publicado: (2015)

Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
por: Chen, Dan, et al.
Publicado: (2018)

Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2
por: Henden, A., et al.
Publicado: (2023)

Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
por: Crosby, Erika J, et al.
Publicado: (2020)

Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignancies
por: WANG, YI-SHAN, et al.
Publicado: (2013)

Adoptive immunotherapy against ovarian cancer
por: Mittica, Gloria, et al.
Publicado: (2016)

Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021)

Adoptive Immunotherapy and High-Risk Myeloma
por: Duane, Catherine, et al.
Publicado: (2023)

Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
por: Liu, Qiaofei, et al.
Publicado: (2023)

Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery
por: Li, Xiao, et al.
Publicado: (2022)

Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2
por: Morse, Michael A, et al.
Publicado: (2007)

Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?
por: Lin, Yan, et al.
Publicado: (2022)

Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer
por: Hou, Xinxin, et al.
Publicado: (2022)

Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers
por: Zhang, Xiaoli, et al.
Publicado: (2020)

Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer
por: Wang, Min, et al.
Publicado: (2014)

Correlation of gut microbiota with leukopenia after chemotherapy in patients with colorectal cancer
por: Xiaofeng, Ni, et al.
Publicado: (2023)

Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma
por: Wang, Jingyu, et al.
Publicado: (2020)

Adoptive Immunotherapy in Postoperative Hepatocellular Carcinoma: A Systemic Review
por: Xie, Feng, et al.
Publicado: (2012)

Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Recent advances in adoptive cancer immunotherapy in china
por: Zhou, Juhua
Publicado: (2015)

Synthetic immunology: T-cell engineering and adoptive immunotherapy
por: Si, Wen, et al.
Publicado: (2018)

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
por: Hendrickson, Peter G., et al.
Publicado: (2019)

Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection
por: Ouellette, Christopher P.
Publicado: (2022)

The global research of microbiota in colorectal cancer screening: a bibliometric and visualization analysis
por: Zhen, Junhai, et al.
Publicado: (2023)

It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
por: Yao, Shiya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s3m2b21uqcctl79gpfk7qdul79